Ipilimumab retreatment following induction therapy: The expanded access program (EAP) experience

被引：0
|
作者：
Margolin, Kim Allyson
Hamid, Omid
Weber, Jeffrey S.
Pavlick, Anna C.
Hodi, F. Stephen
Amin, Asim
Bennett, Kelly
Michener, Tracy
Minor, David R.
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Angeles Clin & Res Inst, Los Angeles, CA USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Comprehens Melanoma Res Ctr, Tampa, FL USA
[4] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Levine Canc Inst, Charlotte, NC USA
[7] Bristol Myers Squibb, Plainsboro, NJ USA
[8] Calif Pacific Ctr Melanoma Res & Treatment, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9041
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: Data from the Italian cohort of ipilimumab expanded access programme (EAP)
    Ascierto, Paolo Antonio
    Simeone, Ester
    Chiarion-Sileni, Vanna
    Queirolo, Paola
    Del Vecchio, Michele
    Di Guardo, Lorenza
    Guidoboni, Massimo
    Marchetti, Paolo
    Cappellini, Gian Carlo Antonini
    Ferrucci, Pier Francesco
    Cognetti, Francesco
    Bernengo, Maria Grazia
    Guida, Michele
    Marconcini, Riccardo
    Mandala, Mario
    Parmiani, Giorgio
    Rinaldi, Gaetana
    Aglietta, Massimo
    Calabro, Luana
    Maio, Michele
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [42] Avelumab treatment of Australian patients with metastatic Merkel cell carcinoma (mMCC): Experience from an expanded access program (EAP)
    van Hagen, Tom
    Sandhu, Shahneen
    Kasturi, Vijay
    Steer, Christopher
    Khoo, Chloe
    Nordman, Ina
    Hennessy, Meliessa
    Hildemann, Steven
    Reed, Josh
    Hariharan, Subramanian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 173 - 174
  • [43] Ipilimumab for advanced, refractory melanoma: A report of the Israeli cohort of expanded access program
    Shapira-Frommer, Ronnie
    Stephen, Frank
    Ben-Ami, Eytan
    Hamburger, Tamar
    Markel, Gal
    Ospovat, Inna
    Zippel, Douglas
    Merims, Sharon
    Apter, Sara
    Steinberg, Hani
    Silman-Steiberg, Yael
    Peretz, Tamar
    Lotem, Michal
    Schachter, Jacob
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Spanish Melanoma Multidisciplinary Group (GEM): Longterm survivors treated with ipilimumab (IPI) in the expanded access programme (EAP).
    Hernando, Cristina
    Soriano, Virtudes
    Pablo Berros, Jose
    Maria Arance, Ana
    Mujika, Karmele
    Rodriguez Abreu, Delvys
    Alonso, Lorenzo
    Alonso, Martina
    Yapur, Lorena
    Berrocal, Alfonso
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] A study on the long-term survivors in an expanded access program (EAP) of gefitinib in China
    Longyun, L.
    Hui, G.
    Wang, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] NeuroREACH™ Platform for Expanded Access Program (EAP) Trials as the Foundation for Clinical Research of the Future
    Sherman, Alexander
    Podesta, Amanda
    Walker, Jason
    Yu, Hong
    D'Agostino, Derek
    Tarasenko, Natalia
    Sinani, Ervin
    Luppino, Sarah
    Scalia, Jennifer
    Paganoni, Sabrina
    Cudkowicz, Merit
    NEUROLOGY, 2020, 94 (15)
  • [47] STATUS OF EXPANDED ACCESS PROGRAM (EAP) REGISTRATION INTO CLINICALTRIALS. GOV FOLLOWING 21ST CENTURY CURES ACT
    Palacios, L.
    De Cock, E.
    VALUE IN HEALTH, 2019, 22 : S299 - S299
  • [48] Efavirenz expanded access program: North American experience
    Manion, DJ
    Koziak, KZ
    Block, DS
    Montgomery, WC
    Joseph, JL
    Bessen, LJ
    AIDS, 2000, 14 : S23 - S23
  • [49] Canadian cohort expanded-access program of nivolumab plus ipilimumab in advanced melanoma
    Hogg, D.
    Monzon, J. G.
    Ernst, S.
    Song, X.
    McWhirter, E.
    Savage, K. J.
    Skinn, B.
    Romeyer, F.
    Smylie, M.
    CURRENT ONCOLOGY, 2020, 27 (04) : 204 - 214
  • [50] Italian cohort of ipilimumab expanded access programme (EAP): Efficacy, safety, and correlation with mutation status in metastatic melanoma patients
    Queirolo, Paola
    Spagnolo, Francesco
    Altomonte, Maresa
    Chiarion-Sileni, Vanna
    Pigozzo, Jacopo
    Del Vecchio, Michele
    Di Guardo, Lorenza
    Ridolfi, Ruggero
    Scoppola, Alessandro
    Ferrucci, Pier Francesco
    Ferraresi, Virginia
    Bernengo, Maria Grazia
    Guida, Michele
    Marconcini, Riccardo
    Mandala, Mario
    Parmiani, Giorgio
    Rinaldi, Gaetana
    Aglietta, Massimo
    Simeone, Ester
    Ascierto, Paolo Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345